
via news-medical.net
In a new Yale-led study, investigators have revealed previously unknown factors that contribute to the hardening of arteries and plaque growth, which cause heart disease. Their insight is the basis for a promising therapeutic approach to halt and potentially reverse plaque buildup and the progression of disease, the researchers said.
The study was published online by Nature Metabolism.
Current treatments for plaque and hardened arteries, a condition known as atherosclerosis, can slow but not improve the disease. Experts believe that may be due to ongoing inflammation in blood vessels. To understand the factors contributing to this inflammation, the research team focused on a group of proteins, called transforming growth factor beta (TGFß), that regulates a wide range of cells and tissues throughout the body.
Using cultured human cells, the researchers discovered that TGF? proteins trigger inflammation in endothelial cells — the cells that form the inner lining of artery walls — but not in other cell types. With a technique called single cell RNA-seq analysis, which measures the expression of every gene in single cells, they then showed that TGF? induced inflammation in these cells in mouse models. This finding was notable, said the researchers, because TGF? proteins are known to decrease inflammation in other cells in the body.
The researchers also showed that when the TGF? receptor gene is deleted in endothelial cells, both the inflammation and plaque in blood vessels are significantly reduced.
To test this approach as a potential therapy, the team, led by professor of medicine Michael Simons, M.D., used an “interfering” RNA, or RNAi, drug developed at Yale, to disrupt TGFß receptors. Interfering RNA use a gene’s own DNA sequence to turn off or silence the gene. To deliver the drug only to endothelial cells in the blood vessel walls of mice, they employed microscopic particles, or nanoparticles, created by their co-authors at MIT. This strategy reduced inflammation and plaque as effectively as the genetic technique.
The findings identify TGFß signaling as a major cause of chronic vessel wall inflammation, and demonstrate that disruption of this pathway leads to cessation of inflammation and substantial regression of existing plaque, said the scientists.
Based on this discovery, investigators at Yale and MIT have launched a biotech company, VasoRX, Inc., to develop this targeted approach, using the RNAi drug delivered by nanoparticles as a potential therapy for atherosclerosis in people.
Learn more: Yale-led study offers promising approach to reducing plaque in arteries
The Latest on: Atherosclerosis
[google_news title=”” keyword=”atherosclerosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Atherosclerosis
- Harvard Health Publishing answers: What are the most common causes of calf pain?on March 24, 2023 at 2:28 pm
Answered by Dr. Robert H. Shmerling M.D. Senior Faculty Editor, Harvard Health Publishing · 30 years of experience · USA Among the most common causes of calf pain are: • muscle strain or tear • ...
- Atherosclerosis Therapeutics Market Key Vendors, Trends, Sales and Supply, Growth Analysis, and Opportunities in 2023-2030on March 23, 2023 at 11:44 pm
Global Atherosclerosis Therapeutics Market research report offers a detailed analysis of valuable insight into the ...
- Similar Processes Could Link MS With Heart Diseaseon March 22, 2023 at 12:00 pm
Multiple sclerosis (MS) and atherosclerosis both involve an abnormal hardening of body tissue, and recent research suggests they may be linked.
- Study shows connections between multiple sclerosis, heart diseaseon March 22, 2023 at 6:32 am
Multiple sclerosis (MS) and atherosclerosis both involve an abnormal hardening of body tissue, and recent research suggests they may be linked.
- Vascular Proliferation and Atherosclerosis: New Perspectives and Therapeutic Strategieson March 21, 2023 at 5:01 pm
In atherosclerosis, the vascular smooth muscle cell (VSMC) contributes to vessel wall inflammation and lipoprotein retention, as well as to the formation of the fibrous cap that provides stability ...
- Care plan your doctor would usually recommend for arteriosclerosis atherosclerosison March 21, 2023 at 2:28 pm
Overview A condition where the arteries become narrowed and hardened due to buildup of plaque (fats) in the artery wall. Symptoms vary depending on the clogged artery. Symptoms Mild arteriosclerosis ...
- Watching atherosclerosis as it developson March 16, 2023 at 7:45 am
Atherosclerosis, also known as "calcification" of the arteries, can lead to heart attack or stroke and is the leading cause of death worldwide. Several factors, such as high cholesterol, can ...
- Cuproptosis-associated ferroptosis genes linked with immune infiltration in atherosclerosison March 14, 2023 at 5:00 pm
In this study, the authors identify cuproptosis-associated ferroptosis genes in the atherosclerosis microarray of the Gene Expression Omnibus (GEO) database and explored hub gene-mediated immune ...
- Immune infiltration in atherosclerosis is mediated by cuproptosis-associated ferroptosis geneson March 14, 2023 at 11:07 am
In a new study published in the journal Cardiovascular Innovations and Applications, the authors identified cuproptosis-associated ferroptosis genes in the atherosclerosis microarray of the Gene ...
- High Blood Pressure and Atherosclerosison February 28, 2023 at 4:00 pm
How Does Atherosclerosis Relate to High Blood Pressure? Atherosclerosis is plaque buildup in the arteries. When it occurs in the arteries that supply blood to the heart, doctors call it ...
via Bing News